LMOD2 p.Arg437Ser
c.1311G>T · VCV3290993
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1525 | likely benign |
|---|---|---|
| REVEL | 0.012 | strongly benign-leaning |
| SaProt | LLR -2.94 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 1 | GERP 0.12, phastCons 0.18 |
| Regional constraint | o/e 0.93 | unconstrained · MANE · 7,778 bp · p 0.09 · regional, not allelic |
| Overall | ||
| CADD | 4.451 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00167% | 59,834 |
| European (non-Finnish)grpmax | 8.79e-05% | 1,137,430 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LMOD2
- Protein
- p.Arg437Ser
- Coding
- c.1311G>T
- MANE Select
- NM_207163
- Type
- single nucleotide variant
- Location
- chr7:123662897 (GRCh38)
- Gene constraint
- LOEUF 0.984 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 67.14 · 6 PDB
- Residue 437
- a UniProt-annotated variant site (in cmd2g; no protein detected by western blot in cardiac tissue from a homozygous patient); the 'interaction with actin 2' region; the 'disordered' region
Similar variants
- LMOD2 p.Arg231Cys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Glu276Lys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Thr244Met Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Ala23Ser Uncertain significance ★ same condition
- LMOD2 p.Ala23Val Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala287Pro Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala287Thr Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala528Val Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lmod2-p-arg437ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown